Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 303

1.

An update on the pharmacological treatment of obsessive-compulsive disorder.

Fontenelle LF, Nascimento AL, Mendlowicz MV, Shavitt RG, Versiani M.

Expert Opin Pharmacother. 2007 Apr;8(5):563-83. Review.

PMID:
17376013
2.

Obsessive-compulsive disorder: a critical review of therapeutic perspectives.

Schruers K, Koning K, Luermans J, Haack MJ, Griez E.

Acta Psychiatr Scand. 2005 Apr;111(4):261-71. Review.

PMID:
15740462
3.

Pharmacological augmentation strategies for treatment-resistant obsessive-compulsive disorder.

Walsh KH, McDougle CJ.

Expert Opin Pharmacother. 2004 Oct;5(10):2059-67. Review.

PMID:
15461541
4.

Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review.

Dell'Osso B, Nestadt G, Allen A, Hollander E.

J Clin Psychiatry. 2006 Apr;67(4):600-10. Review.

PMID:
16669725
5.

Do antipsychotics ameliorate or exacerbate Obsessive Compulsive Disorder symptoms? A systematic review.

Sareen J, Kirshner A, Lander M, Kjernisted KD, Eleff MK, Reiss JP.

J Affect Disord. 2004 Oct 15;82(2):167-74. Review.

PMID:
15488245
6.

Pharmacotherapy for obsessive-compulsive disorder.

Dougherty DD, Rauch SL, Jenike MA.

J Clin Psychol. 2004 Nov;60(11):1195-202.

PMID:
15389617
7.

Pharmacological management of obsessive-compulsive disorder: a review for clinicians.

McDonough M, Kennedy N.

Harv Rev Psychiatry. 2002 May-Jun;10(3):127-37. Review.

PMID:
12023928
8.

Amisulpiride augmentation in treatment resistant obsessive-compulsive disorder: an open trial.

Metin O, Yazici K, Tot S, Yazici AE.

Hum Psychopharmacol. 2003 Aug;18(6):463-7.

PMID:
12923825
9.

Treatment strategies for obsessive-compulsive disorder.

Marazziti D, Consoli G.

Expert Opin Pharmacother. 2010 Feb;11(3):331-43. doi: 10.1517/14656560903446948. Review.

PMID:
20102301
10.

Pharmacotherapy for obsessive-compulsive disorder.

Greist JH, Jefferson JW.

Br J Psychiatry Suppl. 1998;(35):64-70. Review.

PMID:
9829028
11.

Pharmacological treatment of obsessive-compulsive disorder.

Simpson HB.

Curr Top Behav Neurosci. 2010;2:527-43. Review.

PMID:
21309125
12.

[Cognitive-behavior therapy for obsessive-compulsive disorder: a systematic review of the last decade].

Prazeres AM, Souza WF, Fontenelle LF.

Rev Bras Psiquiatr. 2007 Sep;29(3):262-70. Epub 2007 Sep 18. Review. Portuguese.

13.

Pharmacotherapy for obsessive-compulsive disorder.

Hollander E, Kaplan A, Allen A, Cartwright C.

Psychiatr Clin North Am. 2000 Sep;23(3):643-56. Review.

PMID:
10986733
14.

Pharmacotherapy of obsessive-compulsive disorder: experience with the selective serotonin reuptake inhibitors.

Vythilingum B, Cartwright C, Hollander E.

Int Clin Psychopharmacol. 2000 Aug;15 Suppl 2:S7-13. Review.

PMID:
11110014
15.
16.

Augmentation strategies in obsessive-compulsive disorder.

Arumugham SS, Reddy JY.

Expert Rev Neurother. 2013 Feb;13(2):187-202; quiz 203. doi: 10.1586/ern.12.160. Review.

PMID:
23368806
17.

Obsessive-compulsive disorder: diagnosis and treatment.

Goodman WK.

J Clin Psychiatry. 1999;60 Suppl 18:27-32. Review.

18.

New pharmacotherapeutic approaches to obsessive-compulsive disorder.

Figee M, Denys D.

CNS Spectr. 2009 Feb;14(2 Suppl 3):13-23.

PMID:
19238126
19.

The medical treatment of obsessive-compulsive disorder and anxiety.

Bandelow B.

CNS Spectr. 2008 Sep;13(9 Suppl 14):37-46. Review.

PMID:
18849910
20.

The role of dopamine in obsessive-compulsive disorder: preclinical and clinical evidence.

Denys D, Zohar J, Westenberg HG.

J Clin Psychiatry. 2004;65 Suppl 14:11-7.

Supplemental Content

Support Center